The medical community today faces a deceptively simple question: How quickly should we act when a child’s life is on the line? I’m a pediatric oncologist, so my answer won’t surprise you — I think we ...

Asparaginase treatment is standard in all pediatric acute lymphoblastic leukemia (ALL) regimens, whereas in adults, it is either excluded or administered for a shorter duration. Several adult ALL ...

HealthDay News — The FDA has approved a pediatric dose of the cancer drug everolimus (Afinitor Disperz, Novartis), to treat rare brain tumors in children aged 1 year and older. Prior to approval of ...

"The allogeneic stem cell transplant population, especially within the first year posttransplant, is one of the most immune-suppressed populations, therefore placing them at high risk for infectious ...